Literature DB >> 9143705

Transcription factors of the NFAT family: regulation and function.

A Rao1, C Luo, P G Hogan.   

Abstract

As targets for the immunosuppressive drugs cyclosporin A and FK506, transcription factors of the NFAT (nuclear factor of activated T cells) family have been the focus of much attention. NFAT proteins, which are expressed in most immune-system cells, play a pivotal role in the transcription of cytokine genes and other genes critical for the immune response. The activity of NFAT proteins is tightly regulated by the calcium/calmodulin-dependent phosphatase calcineurin, a primary target for inhibition by cyclosporin A and FK506. Calcineurin controls the translocation of NFAT proteins from the cytoplasm to the nucleus of activated cells by interacting with an N-terminal regulatory domain conserved in the NFAT family. The DNA-binding domains of NFAT proteins resemble those of Rel-family proteins, and Rel and NFAT proteins show some overlap in their ability to bind to certain regulatory elements in cytokine genes. NFAT is also notable for its ability to bind cooperatively with transcription factors of the AP-1 (Fos/Jun) family to composite NFAT:AP-1 sites, found in the regulatory regions of many genes that are inducibly transcribed by immune-system cells. This review discusses recent data on the diversity of the NFAT family of transcription factors, the regulation of NFAT proteins within cells, and the cooperation of NFAT proteins with other transcription factors to regulate the expression of inducible genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143705     DOI: 10.1146/annurev.immunol.15.1.707

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  715 in total

Review 1.  Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation.

Authors:  A Ray; L Cohn
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  COMPEL: a database on composite regulatory elements providing combinatorial transcriptional regulation.

Authors:  O V Kel-Margoulis; A G Romashchenko; N A Kolchanov; E Wingender; A E Kel
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

3.  Non FcR-binding murine antihuman CD3 monoclonal antibody is capable of productive TCR signalling and induces proliferation in the presence of costimulation.

Authors:  R T Meijer; S L Yong; I J ten Berge; R A van Lier; P T Schellekens
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

4.  Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation.

Authors:  S Matsuda; F Shibasaki; K Takehana; H Mori; E Nishida; S Koyasu
Journal:  EMBO Rep       Date:  2000-11       Impact factor: 8.807

Review 5.  Small GTPases in lymphocyte biology: Rho proteins take center stage.

Authors:  S Henning; S Cleverley
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

6.  NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun.

Authors:  C Lopez-Rodríguez; J Aramburu; A S Rakeman; A Rao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

7.  Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway.

Authors:  C Nataraj; M I Oliverio; R B Mannon; P J Mannon; L P Audoly; C S Amuchastegui; P Ruiz; O Smithies; T M Coffman
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

8.  A second calcineurin binding site on the NFAT regulatory domain.

Authors:  S Park; M Uesugi; G L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

9.  Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition.

Authors:  D O Cowley; B J Graves
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

Review 10.  Regulatory and signaling properties of the Vav family.

Authors:  X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.